Patent details
EP2068880 Title: METHOD FOR TREATING CANCER HARBORING EGFR MUTATIONS
Basic Information
- Publication number:
- EP2068880
- PCT Application Number:
- PCT/EP/2007/059735
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP078202355
- PCT Publication Number:
- WO/2008/034776
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHOD FOR TREATING CANCER HARBORING EGFR MUTATIONS
- French Title of Invention:
- PROCÉDÉ DE TRAITEMENT DU CANCER PRÉSENTANT DES MUTATIONS EGFR
- German Title of Invention:
- VERFAHREN ZUR BEHANDLUNG VON TUMOREN MIT EGFR-MUTATIONEN
- SPC Number:
Dates
- Filing date:
- 14/09/2007
- Grant date:
- 11/04/2012
- EP Publication Date:
- 11/04/2012
- PCT Publication Date:
- 27/03/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/06/2009
- EP B1 Publication Date:
- 11/04/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/09/2027
- Renunciation date:
- Revocation date:
- 13/05/2014
- Annulment date:
Owner
- From:
- 14/09/2007
- Name:
- Boehringer Ingelheim International GmbH
- Address:
- Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)
- Name:
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Address:
- Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)
Inventor
- Name:
- SOLCA Flavio
- Address:
- Austria (AT)
Priority
1
- Priority Number:
- 06120856
- Priority Date:
- 18/09/2006
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 07101505
- Priority Date:
- 31/01/2007
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 31/517;
| Filing date | Document type | Number of pages |
|---|